RA Capital Management, L.P. 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:47 pm Purchase | 2026-03-31 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 12,974,599 8.900% | 10,108 (+0.08%) | Filing |
| 2025-05-15 4:51 pm Purchase | 2025-03-31 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 12,964,491 9.900% | 314,763 (+2.49%) | Filing |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 12,649,728 9.990% | 2,964,649 (+30.61%) | Filing |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 9,685,079 9.990% | 1,531,520 (+18.78%) | Filing |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 8,153,559 9.990% | 4,287,751 (+110.91%) | Filing |